BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11550547)

  • 1. [Specific characteristics of composition of synthetic nutrient media for cultivation of Hemophilus influenzae type b from the standpoint of bacterial metabolism].
    Orlova OE; Iastrebova NE; Elkina SI
    Zh Mikrobiol Epidemiol Immunobiol; 2001; (3):111-7. PubMed ID: 11550547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dynamics of growth of Haemophilus influenzae serotype B and synthesis of capsular polysaccharide in the process of cultivation in a synthetic nutrient medium].
    Orlova OE
    Zh Mikrobiol Epidemiol Immunobiol; 2002; (2):75-7. PubMed ID: 12043160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of polysaccharide production of haemophilus influenzae Type b and its relationship to bacterial cell growth.
    Takagi M; Cabrera-Crespo J; Baruque-Ramos J; Zangirolami TC; Raw I; Tanizaki MM
    Appl Biochem Biotechnol; 2003 Aug; 110(2):91-100. PubMed ID: 14515024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influence of nicotinamide adenine dinucleotide and hemin concentrations on the growth of Haemophilus influanzae type b and the synthesis of capsular polysaccharide].
    Orlova OE; Elkina SI; Iastrebova NE; Vaneeva NP; Sergeev VV; Kalina NG; Tokarskaia MM
    Zh Mikrobiol Epidemiol Immunobiol; 2005; (4):12-5. PubMed ID: 16146219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two variants among Haemophilus influenzae serotype b strains with distinct bcs4, hcsA and hcsB genes display differences in expression of the polysaccharide capsule.
    Schouls L; van der Heide H; Witteveen S; Zomer B; van der Ende A; Burger M; Schot C
    BMC Microbiol; 2008 Feb; 8():35. PubMed ID: 18298818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental design and metabolic flux analysis tools to optimize industrially relevant Haemophilus influenzae type b growth medium.
    da Silva MR; Andreia Freixo Portela C; Maria Ferreira Albani S; Rizzo de Paiva P; Massako Tanizaki M; Zangirolami TC
    Biotechnol Prog; 2017 Nov; 33(6):1508-1519. PubMed ID: 28840658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influence of the aminopeptide concentration on the growth of Haemophilus influenzae, type b, and the synthesis of its capsular polysaccharide].
    Orlova OE; Elkina SI; Iastrebova NE; Vaneeva NP; Sergeev VV; Kalina NG; Tokarskaia MM
    Zh Mikrobiol Epidemiol Immunobiol; 2005; (3):92-5. PubMed ID: 16028527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of the chemical stability of the capsular polysaccharide produced by Haemophilus influenzae type b.
    Cintra Fde O; Takagi M
    Carbohydr Polym; 2015 Feb; 116():167-72. PubMed ID: 25458286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement in the purification process of the capsular polysaccharide from Haemophilus influenzae type b by using tangential ultrafiltration and diafiltration.
    Albani SM; da Silva MR; Takagi M; Cabrera-Crespo J
    Appl Biochem Biotechnol; 2012 Aug; 167(7):2068-75. PubMed ID: 22665219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A synthetic conjugate polysaccharide vaccine against Haemophilus influenzae type b.
    Verez-Bencomo V; Fernández-Santana V; Hardy E; Toledo ME; Rodríguez MC; Heynngnezz L; Rodriguez A; Baly A; Herrera L; Izquierdo M; Villar A; Valdés Y; Cosme K; Deler ML; Montane M; Garcia E; Ramos A; Aguilar A; Medina E; Toraño G; Sosa I; Hernandez I; Martínez R; Muzachio A; Carmenates A; Costa L; Cardoso F; Campa C; Diaz M; Roy R
    Science; 2004 Jul; 305(5683):522-5. PubMed ID: 15273395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemophilus influenzae type b polysaccharide-protein conjugate vaccines in children.
    Eskola J; Takala AK; Käyhty H
    Curr Opin Pediatr; 1993 Feb; 5(1):55-9. PubMed ID: 8374627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nationwide population-based surveillance of invasive Haemophilus influenzae diseases in children after the introduction of the Haemophilus influenzae type b vaccine in Japan.
    Suga S; Ishiwada N; Sasaki Y; Akeda H; Nishi J; Okada K; Fujieda M; Oda M; Asada K; Nakano T; Saitoh A; Hosoya M; Togashi T; Matsuoka M; Kimura K; Shibayama K
    Vaccine; 2018 Sep; 36(38):5678-5684. PubMed ID: 30122645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Responses of children immunized with capsular polysaccharide of Hemophilus influenzae type b, by David H. Smith, MD, et al, Pediatrics, 1973;52:637-644; and Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100 000 vaccinees 3 months to 5 years of age in Finland, by Heikki Peltola, MD et al, Pediatrics, 1977;60:730-737.
    Peter CG
    Pediatrics; 1998 Jul; 102(1 Pt 2):252-4. PubMed ID: 9651448
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunological characterization of conjugated Haemophilus influenzae type b vaccine failure in infants.
    Breukels MA; Spanjaard L; Sanders LA; Rijkers GT
    Clin Infect Dis; 2001 Jun; 32(12):1700-5. PubMed ID: 11360210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a high-resolution magic-angle spinning nuclear magnetic resonance identity assay of the capsular polysaccharide from Haemophilus influenzae type b present in cetavlon precipitate.
    Wieruszeski JM; Talaga P; Lippens G
    Anal Biochem; 2005 Mar; 338(1):20-5. PubMed ID: 15707931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPAEC-PAD method for the analysis of alkaline hydrolyzates of Haemophilus influenzae type b capsular polysaccharide.
    de Haan A; van der Put RM; Beurret M
    Biomed Chromatogr; 2013 Sep; 27(9):1137-42. PubMed ID: 23681893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conjugate vaccines for preventing Haemophilus influenzae type b infections.
    Swingler G; Fransman D; Hussey G
    Cochrane Database Syst Rev; 2003; (4):CD001729. PubMed ID: 14583937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Validation of an ELISA assay for the quantification of antibodies against Haemophilus influenzae type b capsular polysaccharide].
    Toraño Peraza G; Hernández Vadell I; Baly A; Toledo Romaní ME
    Rev Cubana Med Trop; 2005; 57(3):185-91. PubMed ID: 17969271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polysaccharide purification from Haemophilus influenzae type b through tangential microfiltration.
    Albani SM; da Silva MR; Fratelli F; Junior CP; Iourtov D; Cintra Fde O; Takagi M; Cabrera-Crespo J
    Carbohydr Polym; 2015 Feb; 116():67-73. PubMed ID: 25458274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating innate and adaptive immunity against anti-Haemophilus influenzae type b.
    Zarei AE; Linjawi MH; Redwan EM
    Hum Antibodies; 2019; 27(3):201-212. PubMed ID: 30958343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.